Advertisement

Hollywood’s Ryan Reynolds joins fight for Edmonton toddler needing $2.8M life-saving drug

Click to play video: 'Family of Edmonton toddler pleads for help to pay for new $2.8M gene therapy'
Family of Edmonton toddler pleads for help to pay for new $2.8M gene therapy
Kaysen Martin's family has met with Alberta's health minister to ask for the cost of a new drug be covered. The government is making no promises, but Kaysen's family is getting help from thousands of others who are donating to Kaysen's cause — including actor Ryan Reynolds. Fletcher Kent has more – Jul 6, 2020

A little Alberta boy with a rare disease desperate to secure a multi-million dollar drug just got a boost from a famous Canadian actor.

Ryan Reynolds has pledged $5,000 toward Kaysen’s Quest.

Kaysen Martin needs a life-saving gene therapy for spinal muscular atrophy Type 1 (SMA 1). Zolgensma costs $2.8 million and has to be administered before a patient’s second birthday.

For Martin, that’s on July 17.

A gofundme campaign caught the attention of Vancouver-born Reynolds, as well as internet juggernaut Jillian Harris, who called on her 1.2 million followers to support Kaysen, and other kids with SMA 1.

Social media influencer Jillian Harris called on her 1.2 million followers to support Edmonton’s Kaysen Martin and his quest to secure a life-saving drug. Credit: Jillian Harris

Martin’s mother, Lana Bernardin, said she saw Ryan Reynolds’ donation.

Story continues below advertisement

“Never in a million years did I think someone like Ryan Reynolds would notice my son and his campaign. It meant the world to me.”

The latest health and medical news emailed to you every Sunday.

The gofundme attention had raised more than $70,000 in the last day and although that remains a long way away from the $2.8 million required, it makes Bernardin happy.

“I really have no words. The outpouring of support from so many people is so amazing.”

Nearly two-year-old Martin was diagnosed with spinal muscular atrophy Type 1 (SMA 1) when he was eight months old. It’s a progressive motor neuron disease that causes his muscles to weaken over time.

About one in 6,000 babies are born with SMA. Most children with SMA 1 do not live to see their second birthdays.

READ MORE: Edmonton family asks province to fund life-saving, multi-million-dollar drug for toddler

Martin already receives doses of another drug, Spinraza. But it’s not a cure and it costs $375,000 a year.

Zolgensma would be a one-time treatment.

Click to play video: 'Edmonton family asks province to fund life-saving, multi-million-dollar drug for toddler'
Edmonton family asks province to fund life-saving, multi-million-dollar drug for toddler

Both Bernardin and a group of other parents with children with special needs say the fundraising campaign isn’t their primary goal. They’d like the province to help pay for the drug.

Story continues below advertisement

Catherine Bangel helped coordinate the gofundme campaign.

“We hope that the more money we raise and the more attention we bring to Kaysen and all kids with SMA, we hope that we can pressure the government to fund this going forward,” Bangel said.

“We’ll try to get as far as we can. We’d love it if the Alberta government would join our fight.”

Last week, Alberta Health Minister Tyler Shandro said options are limited since Zolgensma has not yet received Health Canada approval. But the Martin family says Health Canada has approved Martin for treatment through its Special Access Program – meaning he doesn’t need to wait.

Since then, Bernardin has met with Health Minister Tyler Shandro. She asked for provincial help paying for the uninsured treatment but received no assurances. She’s not angry, though.

“He listened. He heard me and I appreciate the fact that he can’t say too much.”

Shandro said the meeting was helpful.

“At this time, we don’t have an further updates but we did tell the family we would be back in touch with them.”

READ MORE: ‘Devastating’: B.C. parents fighting to raise millions for three-month-old daughter’s treatment

With files from Nicole Stillger, Global News.

Advertisement

Sponsored content

AdChoices